| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | -58.6% | -90.2% |
| Cost of Revenue | $1.1M | -58.5% | -89.3% |
| Gross Profit | $6K | -66.7% | -99.4% |
| R&D Expense | $276K | -22.5% | -1.1% |
| SG&A Expense | $575K | -18.2% | -6.4% |
| Operating Income | -$845K | +16.4% | -868.2% |
| Pre-tax Income | -$603K | +18.7% | -255.4% |
| Net Income | -$603K | +18.7% | -255.4% |
| EPS (Basic) | -$0.07 | +22.2% | -240.0% |
| EPS (Diluted) | -$0.07 | +22.2% | -240.0% |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.0M | +37.7% | +66.9% |
| Accounts Receivable | $1.6M | -11.7% | +488.9% |
| Inventory | $4.9M | +24.5% | -63.9% |
| Current Assets | $12.4M | +21.5% | -31.8% |
| Total Assets | $16.3M | +14.3% | -29.9% |
| Current Liabilities | $13.6M |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.6M | +333.2% | — |
| Capital Expenditures | $44K | +46.7% | — |
| Investing Cash Flow | -$16K | -1500.0% | — |
| Financing Cash Flow | -$230K | -98.3% | — |
| Free Cash Flow | $1.5M | +359.2% | — |
| -24.1% |
| Long-term Debt | $193K | -37.3% | -69.2% |
| Total Liabilities | $14.8M | +21.3% | -24.7% |
| Stockholders' Equity | $1.5M | -27.3% | -58.2% |